ID1 and neoplasm: In our clinical analysis, the size of primary tumor of NSCLC patients with high Id1 expression was in average larger than that of the patients with low Id1 expression before the definitive adjuvant chemotherapy (Table 1), implying that Id1 acted as a negative prognostic factor in NSCLC.